These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9974375)

  • 41. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
    Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
    Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular markers for the blood coagulation and fibrinolysis].
    Okajima K
    Rinsho Byori; 2001 Mar; Suppl 115():74-90. PubMed ID: 11391940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
    Kotajima N; Kanda T; Fukumura Y; Kobayashi I
    J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation.
    Lehman CM; Wilson LW; Rodgers GM
    Am J Clin Pathol; 2004 Aug; 122(2):178-84. PubMed ID: 15323133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Latex immunoturbidimetric assay for soluble fibrin complex.
    Hamano A; Umeda M; Ueno Y; Tanaka S; Mimuro J; Sakata Y
    Clin Chem; 2005 Jan; 51(1):183-8. PubMed ID: 15514091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The fibrinogen functional turbidimetric assay.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):84-96. PubMed ID: 18160594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disseminated intravascular coagulation (DIC).
    Mammen EF
    Clin Lab Sci; 2000; 13(4):239-45. PubMed ID: 11586511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis.
    Hanly JG; Smith SA; Anderson D
    J Rheumatol; 2003 Sep; 30(9):1990-3. PubMed ID: 12966603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a point of care lateral flow device for measuring human plasma fibrinogen.
    Dudek MM; Lindahl TL; Killard AJ
    Anal Chem; 2010 Mar; 82(5):2029-35. PubMed ID: 20131873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Mosesson MW
    Thromb Diath Haemorrh Suppl; 1973; 56():75-90. PubMed ID: 4218377
    [No Abstract]   [Full Text] [Related]  

  • 52. Thrombin treated plasma employed as a standard for determination of soluble fibrin.
    Halvorsen S; Skjønsberg OH; Godal HC
    Thromb Res; 1993 Nov; 72(4):305-13. PubMed ID: 8303670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soluble fibrin complexes in experimental thrombotic states.
    Chang ML; Wilson JE; Frenkel EP
    J Lab Clin Med; 1974 Aug; 84(2):168-78. PubMed ID: 4843224
    [No Abstract]   [Full Text] [Related]  

  • 54. The amount of fibrin necessary to give a positive ethanol gelation test at various fibrinogen levels.
    Slaastad RA; Godal HC; Kierulf P
    Scand J Haematol; 1975 Sep; 15(2):153-60. PubMed ID: 1188318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of fibrin in plasma by a monoclonal antibody against the amino-terminus of the alpha-chain of fibrin.
    Müller-Berghaus G; Scheefers-Borchel U; Fuhge P; Eberle R; Heimburger N
    Scand J Clin Lab Invest Suppl; 1985; 178():145-51. PubMed ID: 3867115
    [No Abstract]   [Full Text] [Related]  

  • 56. Rapid-SF: a rapid whole-blood screen for soluble fibrin monomer.
    Hay KL; Bull BS
    Thromb Haemost; 2002 Nov; 88(5):773-80. PubMed ID: 12428093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ethanol gelation test and thrombosis.
    Godal HC; Brosstad F; Kierulf P
    Bibl Haematol; 1977; 44():156-60. PubMed ID: 617779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Poor correlation between soluble fibrin concentrations measured by two commercially available immunoassays.
    Rahr HB; Danielsen D; Andersen BS; Borris LC; Lassen MR
    Thromb Res; 1996 Mar; 81(6):607-14. PubMed ID: 8868510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fibrinogen concentration: A marker of cardiovascular disorders in Nigerians.
    Ajayi OI; Famodu AA; Oviasu E
    Turk J Haematol; 2007 Mar; 24(1):18-22. PubMed ID: 27263480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in the fibrinolytic power of the blood in atherosclerotic subjects with and without active or prior thrombotic complications].
    CAMERADA P; CONGIU M; LEO P
    Rass Med Sarda; 1959; 61():827-37. PubMed ID: 13807115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.